Michael Serenko, MD
- 2Articles
- 16.8KReads1
- 2015Active
- 5Collaborators
- 146Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Michael Serenko, MD, has published research focused on the treatment of major depressive disorder (MDD), specifically investigating the efficacy and safety of different doses of vortioxetine in adults. His work includes randomized, double-blind, placebo-controlled clinical trials assessing this antidepressant. Serenko has collaborated frequently with co-authors such as Atul R. Mahableshwarkar and Madhukar H. Trivedi.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
